Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 15, 1996 - Issue 3
3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

The putative role of cytokine-orbital fibroblast interactions in the pathogenesis of thyroid-associated ophthalmopathy

Pages 137-146 | Accepted 20 Feb 1996, Published online: 08 Jul 2009
 

Abstract

Orbital fibroblasts appear to possess phenotypic attributes that set them apart from fibroblasts derived from the skin. Among the differences between orbital and dermal fibroblasts are responses to inflammatory mediators such as the lymphokine, leukoregulin. This lymphokine causes a marked upregulation of hyaluronan synthesis in orbital fibroblasts. The magnitude of this cellular response is considerably greater than that observed in dermal fibroblasts. Leukoregulin also increases the expression of plasminogen activator inhibitor type-1 and prostaglandin E2 synthesis dramatically in orbital fibroblasts. The author hypothesizes that these anatomic site-selective actions of leukoregulin in orbital fibroblasts represent the molecular basis for the two central features of tissue reorganization associated with Graves' ophthalmopathy, disordered accumulation of glycosaminoglycans and intense inflammation. His findings begin to define a potentially useful model for the design of specific therapeutic modalities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.